| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |